Modulation of IL-8 boosted by mycoplasma pneumoniae lysate in human airway epithelial cells

Journal of Clinical Immunology

Volumn 33, Issue 6, 2013, Pages 1117-1125

  Lee, Kyung Eun ^a   Kim, Kyung Won ^a   Hong, Jung Yeon ^a   Kim, Kyu Earn ^a   Sohn, Myung Hyun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

airway epithelial cell; ERK; IL 8; Mycoplasma pneumoniae; NF IL6; TLR2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MYCOPLASMA PNEUMONIAE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIBODIES, BLOCKING; ANTIGENS, BACTERIAL; BUTADIENES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLS, CULTURED; FLAVONOIDS; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HUMANS; INTERLEUKIN-8; MAP KINASE SIGNALING SYSTEM; MYCOPLASMA PNEUMONIAE; NF-KAPPA B; NITRILES; PROMOTER REGIONS, GENETIC; RESPIRATORY MUCOSA; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 2; TRANSCRIPTIONAL ACTIVATION;

EID: 84880316344     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9909-y     Document Type: Article

References (39)

1. Weisburg WG, Tully JG, Rose DL, Petzel JP, Oyaizu H, Yang D, et al. A phylogenetic analysis of the mycoplasmas: basis for their classification. J Bacteriol. 1989;171(12):6455-67. (Pubitemid 20006922)
2. Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy. 1993;70(1):23-5. (Pubitemid 23042030)
3. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 1998;158(3):998-1001. (Pubitemid 28449473)
4. Sutherland ER, Brandorff JM, Martin RJ. Atypical bacterial pneumonia and asthma risk. J Asthma. 2004;41(8):863-8. (Pubitemid 40019138)
5. Chmura K, Bai X, Nakamura M, Kandasamy P, McGibney M, Kuronuma K, et al. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol. 2008;295(1):L220-30.
6. Shimizu T, Kida Y, Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6. J Immunol. 2005;175(7):4641-6. (Pubitemid 41362004)
7. Rawadi G, Roman-Roman S. Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect Immun. 1996;64(2):637-43. (Pubitemid 26032841)
8. Smith PF. Membrane lipid and lipopolysaccharide structures. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology and pathogenesis. Washington: American Society for Microbiology; 1992. p. 79-91.
9. Wieslander A, Boyer MJ, Wroblewski H. Membrane protein structure. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology and pathogenesis. Washington: American Society for Microbiology; 1992. p. 93-112.
10. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-76. (Pubitemid 37174535)
11. Zuo LL, Wu YM, You XX. Mycoplasma lipoproteins and Toll-like receptors. J Zhejiang Univ Sci B. 2009;10(1):67-76.
12. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460-9. (Pubitemid 350086981)
13. Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med. 2007;13(3):117-24. (Pubitemid 46341960)
14. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, et al. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem. 2006;281(41):31002-11. (Pubitemid 44582155)
15. Pease JE, Sabroe I. The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy. Am J Respir Med. 2002;1(1):19-25. (Pubitemid 37038920)
16. Bohnet S, Kotschau U, Braun J, Dalhoff K. Role of interleukin-8 in community-acquired pneumonia: relation to microbial load and pulmonary function. Infection. 1997;25(2):95-100. (Pubitemid 27145845)
17. Martin LD, Rochelle LG, Fischer BM, Krunkosky TM, Adler KB. Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J. 1997;10(9):2139-46. (Pubitemid 27406456)
18. Akhtar M, Watson JL, Nazli A, McKay DM. Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaB-independent pathway. FASEB J. 2003;17(10):1319-21.
19. Cheon IS, Woo SS, Kang SS, Im J, Yun CH, Chung DK, et al. Peptidoglycan-mediated IL-8 expression in human alveolar type II epithelial cells requires lipid raft formation and MAPK activation. Mol Immunol. 2008;45(6):1665-73. (Pubitemid 351221140)
20. Henriquet C, Gougat C, Combes A, Lazennec G, Mathieu M. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells. Lung Cancer. 2007;56(2):167-74. (Pubitemid 46590485)
21. Kim YM, Reed W, Wu W, Bromberg PA, Graves LM, Samet JM. Zn2+-induced IL-8 expression involves AP-1, JNK, and ERK activities in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;290(5):L1028-35. (Pubitemid 43738988)
22. Khanjani S, Terzidou V, Johnson MR, Bennett PR. NFkappaB and AP-1 drive human myometrial IL8 expression. Mediators Inflamm. 2012;504952.
23. Lee KE, Kim JW, Jeong KY, Kim KE, Yong TS, Sohn MH. Regulation of German cockroach extract-induced IL-8 expression in human airway epithelial cells. Clin Exp Allergy. 2007;37(9):1364-73. (Pubitemid 47372300)
24. Sohn MH, Lee KE, Choi SY, Kwon BC, Chang MW, Kim KE. Effect of Mycoplasma pneumoniae lysate on interleukin-8 gene expression in human respiratory epithelial cells. Chest. 2005;128(1):322-6. (Pubitemid 40994491)
25. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511. (Pubitemid 38931765)
26. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol. 1999;11(1):13-8. (Pubitemid 29082330)
27. Hughes AL, Piontkivska H. Functional diversification of the toll-like receptor gene family. Immunogenetics. 2008;60(5):249-56.
28. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999;162(7):3749-52. (Pubitemid 29314747)
29. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816-25.
30. Suhir H, Etzioni A. The role of Toll-like receptor signaling in human immunodeficiencies. Clin Rev Allergy Immunol.38(1):11-9.
31. Elliott CL, Allport VC, Loudon JA, Wu GD, Bennett PR. Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod. 2001;7(8):787-90. (Pubitemid 32734303)
32. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol. 2002;72(5):847-55. (Pubitemid 35365158)
33. John AE, Zhu YM, Brightling CE, Pang L, Knox AJ. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter. J Immunol. 2009;183(7):4682-92.
34. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993;90(21):10193-7. (Pubitemid 23328278)
35. Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094-156. (Pubitemid 28558294)
36. Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2003;83(2):417-32. (Pubitemid 36378677)
37. Wren BW. Microbial genome analysis: insights into virulence, host adaptation and evolution. Nat Rev Genet. 2000;1(1):30-9.
38. Chambaud I, Wroblewski H, Blanchard A. Interactions between mycoplasma lipoproteins and the host immune system. Trends Microbiol. 1999;7(12):493-9. (Pubitemid 30017701)
39. Chiba H, Pattanajitvilai S, Evans AJ, Harbeck RJ, Voelker DR. Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids. J Biol Chem. 2002;277(23):20379-85. (Pubitemid 34967333)